Entera Bio Ltd. News, Entera Bio Ltd. Quote, ENTX Quote

Entera Bio Ltd. (NQ:ENTX) Delayed: 2.22 +0.17 (8.29%)

Prev. Close

$2.05

Open

$2.05

52 Wk High

$0.30

52 Wk Low

$0.10

Day High

$2.24

Day Low

$1.97

P/E

N/A

EPS

$0.00

Volume

115,725

Friends, Peers and Foes (?): OPK (more...)

Apr 23, 2024 05:32 PM Form 4 Entera Bio Ltd. For: Apr 19 Filed by: Yaacov-Garbeli Dana
Apr 23, 2024 05:31 PM Form 4 Entera Bio Ltd. For: Apr 19 Filed by: Galitzer Hillel
Apr 8, 2024 08:30 AM Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
Mar 26, 2024 08:32 AM Entera Bio Ltd. (ENTX) Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program
Mar 26, 2024 08:30 AM Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Mont
Mar 20, 2024 08:03 AM Entera Bio Ltd. (ENTX) Announces Robust Pharmacokinetic Data for Oral GLP-2 Peptide Tablet Treatment
Mar 20, 2024 08:01 AM Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
Mar 8, 2024 04:26 PM Form S-8 Entera Bio Ltd.
Mar 8, 2024 04:14 PM Form 10-K Entera Bio Ltd. For: Dec 31
Mar 8, 2024 04:11 PM Form 8-K Entera Bio Ltd. For: Mar 08

Entities mentioned with ENTX